The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
Abstract
Background —Despite intense investigation, the effector of the infarct-limiting protection observed during the late phase of ischemic preconditioning (PC) remains unknown. The goal of this study was to test the hypothesis that late PC against myocardial infarction is mediated by the activity of nitric oxide synthase (NOS). Methods and Results —Conscious rabbits underwent a 30-minute coronary occlusion followed by 3 days of reperfusion. In group I (control group, n=10), infarct size (tetrazolium staining) averaged 56.8±5.3% of the risk region, which was decreased to 27.6±2.5% ( P <0.05) in rabbits preconditioned 24 hours earlier with a sequence of six 4-minute occlusion/4-minute reperfusion cycles (group II, n=10). When preconditioned rabbits were given the nonselective NOS inhibitor N ω -nitro- l -arginine (L-NA, 13 mg/kg IV [group III, n=8]) or the selective iNOS inhibitor aminoguanidine (AG, 150 mg/kg SC [group V, n=7]) before the 30-minute occlusion, the protective effect of late PC was completely abrogated; that is, infarct size (59.9±4.5% and 65.8±3.3%, respectively) was similar to that measured in the control group. Measurements of systolic wall thickening (sonomicrometry) demonstrated that L-NA and AG also abolished the improved recovery of myocardial function effected by late PC in group II. When rabbits were given L-NA or AG without prior PC (group IV [n=8] and group VI [n=6], respectively), infarct size did not differ from that observed in controls (53.8±4.3% and 59.8±4.3%, respectively), demonstrating that L-NA and AG do not increase the extent of cell death in nonpreconditioned myocardium. Conclusions —Taken together, these results indicate that in the conscious rabbit, the infarct-sparing effect of the late phase of ischemic PC is mediated by the activity of NOS and suggest that the specific isoform primarily responsible for this cardioprotective phenomenon is iNOS. Thus, NO appears to be a pivotal component of the pathophysiological cascade of late PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Marber, M. S., Latchman, D. S., Walker, J. M., & Yellon, D. M. (1993) · Circulation · doi:10.1161/01.cir.88.3.1264 · Cited by 1,001
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., & Currie, M. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90357-n · Cited by 721
Nitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., & Yazaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119709 · Cited by 687
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia.
Kuzuya, T., Hoshida, S., Yamashita, N., Fuji, H., Oe, H., Hori, M., Kamada, T., & Tada, M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1293 · Cited by 628
Schulz, R., Nava, E., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09021.x · Cited by 612
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
Southan, G. J., & Szabó, C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02099-3 · Cited by 569
Huot, J., Houle, F., Marceau, F., & Landry, J. (1997) · Circulation Research · doi:10.1161/01.res.80.3.383 · Cited by 567
Ping, P., Zhang, J., Qiu, Y., Tang, X.-L., Manchikalapudi, S., Cao, X., & Bolli, R. (1997) · Circulation Research · doi:10.1161/01.res.81.3.404 · Cited by 482
Self-citationMéry, P. F., Pavoine, C., Belhassen, L., Pecker, F., & Fischmeister, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74313-0 · Cited by 470
Inducible Nitric Oxide Synthase Gene Expression in Brain following Cerebral Ischemia
Iadecola, C., Zhang, F., Xu, S., Casey, R., & Ross, M. E. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.47 · Cited by 469
Gopalakrishna, R., & Anderson, W. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6758 · Cited by 407
Szabó, C., Southan, G. J., & Thiemermann, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12472 · Cited by 406
Aminoguanidine selectively inhibits inducible nitric oxide synthase
Griffiths, M. J. D., Messent, M., MacAllister, R. J., & Evans, T. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13907.x · Cited by 397
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.
Weyrich, A. S., Ma, X. L., & Lefer, A. M. (1992) · Circulation · doi:10.1161/01.cir.86.1.279 · Cited by 320
Role of nitric oxide in the regulation of oxygen consumption in conscious dogs.
Shen, W., Xu, X., Ochoa, M., Zhao, G., Wolin, M. S., & Hintze, T. H. (1994) · Circulation Research · doi:10.1161/01.res.75.6.1086 · Cited by 317
Bolli, R., Manchikalapudi, S., Tang, X.-L., Takano, H., Qiu, Y., Guo, Y., Zhang, Q., & Jadoon, A. K. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1094 · Cited by 313
Self-citationTilton, R. G., Chang, K., Hasan, K. S., Smith, S. R., Petrash, J. M., Misko, T. P., Moore, W. M., Currie, M. G., Corbett, J. A., McDaniel, M. L., et al. (1993) · Diabetes · doi:10.2337/diab.42.2.221 · Cited by 293
Baxter, G. F., Marber, M. S., Patel, V. C., & Yellon, D. M. (1994) · Circulation · doi:10.1161/01.cir.90.6.2993 · Cited by 272
Shen, W., Hintze, T. H., & Wolin, M. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3505 · Cited by 264
Bolli, R., Bhatti, Z. A., Tang, X.-L., Qiu, Y., Zhang, Q., Guo, Y., & Jadoon, A. K. (1997) · Circulation Research · doi:10.1161/01.res.81.1.42 · Cited by 251
Self-citationSun, J. Z., Tang, X. L., Park, S. W., Qiu, Y., Turrens, J. F., & Bolli, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118449 · Cited by 247
Self-citationSun, J. Z., Tang, X. L., Knowlton, A. A., Park, S. W., Qiu, Y., & Bolli, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117667 · Cited by 241
Self-citationWatanabe, A. M., & Besch, H. R. (1975) · Circulation Research · doi:10.1161/01.res.37.3.309 · Cited by 230
Xie, Y.-W., Shen, W., Zhao, G., Xu, X., Wolin, M. S., & Hintze, T. H. (1996) · Circulation Research · doi:10.1161/01.res.79.3.381 · Cited by 229
Bolli, R., Zhu, W.-X., Myers, M. L., Hartley, C. J., & Roberts, R. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90413-8 · Cited by 219
Self-citationActivation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide.
Natarajan, V., Taher, M. M., Roehm, B., Parinandi, N. L., Schmid, H. H., Kiss, Z., & Garcia, J. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54023-0 · Cited by 211
Wu, C., Chen, S., Szabó, C., Thiemermann, C., & Vane, J. R. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14955.x · Cited by 210
Preconditioning does not attenuate myocardial stunning.
Ovize, M., Przyklenk, K., Hale, S. L., & Kloner, R. A. (1992) · Circulation · doi:10.1161/01.cir.85.6.2247 · Cited by 192
DAS, D., MAULIK, N., & MORARU, I. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80017-x · Cited by 185
Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
Nakanishi, K., Vinten-Johansen, J., Lefer, D. J., Zhao, Z., Fowler, W. C., McGee, D. S., & Johnston, W. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.6.h1650 · Cited by 181
Hypoxia/Reoxygenation Stimulates Jun Kinase Activity Through Redox Signaling in Cardiac Myocytes
Laderoute, K. R., & Webster, K. A. (1997) · Circulation Research · doi:10.1161/01.res.80.3.336 · Cited by 174
Induction of nuclear factor κB and activation protein 1 in postischemic myocardium
Chandrasekar, B., & Freeman, G. L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01426-3 · Cited by 162
Baxter, G. F., Goma, F. M., & Yellon, D. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15866.x · Cited by 161
Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning.
Cohen, M. V., Yang, X. M., & Downey, J. M. (1994) · Circulation Research · doi:10.1161/01.res.74.5.998 · Cited by 159
Inhibition of Nitric Oxide Limits Infarct Size in the in Situ Rabbit Heart
Patel, V. C., Yellon, D. M., Singh, K. J., Neild, G. H., & Woolfson, R. G. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1809 · Cited by 158
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits
Qiu, Y., Rizvi, A., Tang, X., Manchikalapudi, S., Takano, H., Jadoon, A. K., Wu, W., & Bolli, R. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.6.h2931 · Cited by 157
Self-citationCyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes
Levi, R. C., Alloatti, G., & Fischmeister, R. (1989) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00581823 · Cited by 152
Inhibition of Nitric Oxide Synthesis Reduces Infarct Size by an Adenosine-Dependent Mechanism
Woolfson, R. G., Patel, V. C., Neild, G. H., & Yellon, D. M. (1995) · Circulation · doi:10.1161/01.cir.91.5.1545 · Cited by 152
Inhibition of nitric oxide formation by guanidines
Hasan, K., Heesen, B., Corbett, J. A., McDaniel, M. L., Chang, K. C., Allison, W., Wolffenbuttel, B. H. R., Williamson, J. R., & Tilton, R. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90667-7 · Cited by 151
Joly, G. A., Ayres, M., Chelly, F. D., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1207 · Cited by 144
Cellular Mechanisms in Ischemic Preconditioning: The Role of Adenosine and Protein Kinase C a
Downey, J. M., Cohen, M. V., Ytrehus, K., & Liu, Y. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb36719.x · Cited by 133
Time Course of Late Preconditioning Against Myocardial Stunning in Conscious Pigs
Tang, X., Qiu, Y., Park, S.-W., Sun, J.-Z., Kalya, A. V., & Bolli, R. (1996) · Circulation Research · doi:10.1161/01.res.79.3.424 · Cited by 128
Self-citationBolli, R. (1996) · Basic Research in Cardiology · doi:10.1007/bf00788866 · Cited by 123
Self-citationEndotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production.
Tilton, R. G., Chang, K., Corbett, J. A., Misko, T. P., Currie, M. G., Bora, N. S., Kaplan, H. J., & Williamson, J. R. (1994) · PubMed · Cited by 116
Infarct limitation of the second window of protection in a conscious rabbit model
Yang, X. M., Baxter, G. F., Heads, R. J., Yellon, D. M., Downey, J. M., & COHEN, M. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00026-0 · Cited by 113
Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits
Liu, J. L., Murakami, H., & Zucker, I. H. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.6.r1361 · Cited by 109
Phospholipase D Plays a Role in Ischemic Preconditioning in Rabbit Heart
Cohen, M. V., Liu, Y., Liu, G. S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.7.1713 · Cited by 97
Qiu, Y., Tang, X., Park, S.-W., Sun, J.-Z., Kalya, A. V., & Bolli, R. (1997) · Circulation Research · doi:10.1161/01.res.80.5.730 · Cited by 87
Self-citationImagawa, J., Baxter, G. F., & Yellon, D. M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0428 · Cited by 82
The cellular basis of angiotensin converting enzyme mRNA expression in rat heart
Paul, M., Stoll, M., Kreutz, R. H., & Fernández‐Alfonso, M. S. (1996) · Basic Research in Cardiology · doi:10.1007/bf00795364 · Cited by 76
Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning
Haessler, R., Kuzume, K., Chien, G. L., et al. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.10.1574 · Cited by 73
Burckhartt, B. A., Yang, X. M., Tsuchida, A., MMullane, K., Downey, J. M., & Cohen, M. V. (1995) · Cardiovascular Research · doi:10.1016/s0008-6363(96)88636-6 · Cited by 68
Weiss, H. R., Rodriguez, E. R., Tse, J., & Scholz, P. M. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02561.x · Cited by 61
Kim, S., Ghaleh, B., Kudej, R. K., Huang, C.-H., Hintze, T. H., & Vatner, S. F. (1997) · Circulation Research · doi:10.1161/01.res.81.1.53 · Cited by 57
Myocardial Adaptation, Stress Proteins, and the Second Window of Protection
Marber, M. S., & Yellon, D. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb33510.x · Cited by 43
Schwartz, L. M., Jennings, R. B., & Reimer, K. A. (1997) · Basic Research in Cardiology · doi:10.1007/bf00805571 · Cited by 36
Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.
Engelman, D. T., Watanabe, M., Maulik, N., Engelman, R. M., Rousou, J. A., Flack, J. E., Deaton, D. W., & Das, D. K. (1996) · PubMed · Cited by 36
Reinhart, G. A., Lohmeier, T. E., & Mizelle, H. L. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.199 · Cited by 26
Cited by
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
The Late Phase of Preconditioning
Bolli, R. (2000) · Circulation Research · doi:10.1161/01.res.87.11.972 · Cited by 757
Self-citationConsequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Metadata
- Authors
- Takano, H., Manchikalapudi, S., Tang, X.-L., Qiu, Y., Rizvi, A., Jadoon, A. K., Zhang, Q., & Bolli, R.
- Venue
- Circulation
- Published
- 1998-08-04
- Volume
- 98
- Issue
- 5
- Pages
- 441-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1964972368
- Cited by
- 256
- References
- 66
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.